Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses

by Lauren M. F. Merlo, James B. DuHadaway, James D. Montgomery, Wei-Dan Peng, Peter J. Murray, George C. Prendergast, George C. Prendergast, George C. Prendergast, Andrew J. Caton, Alexander J. Muller, Laura Mandik-Nayak
Published 2020-08-01

IDO2 in immunomodulation and autoimmunity

by George ePrendergast, Richard eMetz, Alexander J. Muller, Lauren M.F. Merlo, Laura eMandik-Nayak
Published 2014-11-01

Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans

by Valerio Napolioni, Marilena Pariano, Monica Borghi, Vasilis Oikonomou, Claudia Galosi, Antonella De Luca, Claudia Stincardini, Carmine Vacca, Giorgia Renga, Vincenzina Lucidi, Carla Colombo, Ersilia Fiscarelli, Cornelia Lass-Flörl, Alessandra Carotti, Lucia D'Amico, Fabio Majo, Maria Chiara Russo, Helmut Ellemunter, Angelica Spolzino, Paolo Mosci, Stefano Brancorsini, Franco Aversa, Andrea Velardi, Luigina Romani, Claudio Costantini
Published 2019-05-01

Aging-associated increase in indoleamine 2,3-dioxygenase (IDO) activity appears to be unrelated...

by Jylhä Marja, Hervonen Antti, Eklund Carita, Jylhävä Juulia, Marttila Saara, Hurme Mikko
Published 2011-10-01

Pasture vegetation near the village of Iđoš

by Knežević Aleksa S., Ljevnaić-Mašić Branka B., Džigurski Dejana M., Ćupina Branko T.
Published 2014-01-01

IDO and kynurenines in corneal allograft rejection

by Zaher, Sarah Samir Abd-Elazim
Published 2011

IDO1 and IDO2 non-synonymous gene variants: correlation with crohn's disease risk and clinical phenotype.

by Alexander Lee, Navya Kanuri, Yuanhao Zhang, Gregory S Sayuk, Ellen Li, Matthew A Ciorba
Published 2014-01-01

Correction: IDO1 and IDO2 Non-Synonymous Gene Variants: Correlation with Crohn's Disease Risk and Clinical Phenotype.

by Alexander Lee, Navya Kanuri, Yuanhao Zhang, Gregory S Sayuk, Ellen Li, Matthew A Ciorba
Published 2015-01-01

¿Cómo ha ido evolucionando la revista?

by María Carolina Cabrera Schulmeyer
Published 2019-09-01

IDO and Kynurenine Metabolites in Peripheral and CNS Disorders

by Yi-Shu Huang, Joy Ogbechi, Felix I. Clanchy, Richard O. Williams, Trevor W. Stone
Published 2020-03-01

Exploitation of the Ido Pathway in the Therapy of Rheumatoid Arthritis

by Richard O. Williams
Published 2013-07-01

Exploitation of the IDO Pathway in the Therapy of Rheumatoid Arthritis

by Richard O. Williams
Published 2013-01-01

IDO Targeting in Sarcoma: Biological and Clinical Implications

by Imane Nafia, Maud Toulmonde, Doriane Bortolotto, Assia Chaibi, Dominique Bodet, Christophe Rey, Valerie Velasco, Claire B. Larmonier, Loïc Cerf, Julien Adam, François Le Loarer, Ariel Savina, Alban Bessede, Antoine Italiano, Antoine Italiano
Published 2020-03-01

Immunological relevance of the coevolution of IDO1 and AHR

by Francisco Javier Quintana, Merja eJaronen
Published 2014-10-01

On the nonredundant roles of TDO2 and IDO1

by Paolo ePuccetti
Published 2014-10-01

Trial watch: IDO inhibitors in cancer therapy

by Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer, Erika Vacchelli
Published 2020-01-01

Anti-inflammatory role of IDO and tryptophan metabolites

by Salimi Elizei, Sanam
Published 2016

The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells.

by Christiane A Opitz, Ulrike M Litzenburger, Uta Opitz, Felix Sahm, Katharina Ochs, Christian Lutz, Wolfgang Wick, Michael Platten
Published 2011-01-01

IDO2: A Pathogenic Mediator of Inflammatory Autoimmunity

by Lauren M.F. Merlo, Laura Mandik-Nayak
Published 2016-11-01

IDO Expression in Cancer: Different Compartment, Different Functionality?

by Annabel Meireson, Annabel Meireson, Michael Devos, Lieve Brochez, Lieve Brochez
Published 2020-09-01